Protective effects of dexmedetomidine on ischaemia-reperfusion injury in an experimental rat model of priapism
Loading...
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Andrologia
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
The study aimed to investigate the effects of dexmedetomidine against ischaemia-reperfusion injury occurring after priapism in a model of induced-priapism in rats. A total of 18 male rats were randomised into three groups. Group 1 was the control group. A priapism model was performed rats in Group 2 and then ischaemia-reperfusion injury was evaluated. Group 3 had similar procedures to the rats in Group 2. Rats in Group 3 additionally had 100 μg/kg dexmedetomidine administered intraperitoneally immediately after reperfusion. Blood and tissue samples were analysed. Biochemical analysis of blood samples revealed a decrease in the levels of the pro-inflammatory cytokines including interleukin-1 beta (IL-1 Beta), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-alpha) in Group 3 compared to Group 2 (p:.04, p:.009 and p:.009, respectively). Similarly, the highest malondialdehyde (MDA) level was in Group 2 (p:.002). The levels of antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities were significantly higher in Group 3 than that of Group 2 (p:.037 and p:.045, respectively). Direct microscopic examinations revealed positive changes in desquamation, oedema, inflammation and vasocongestion scores in Group 3 compared to Group 2 (p:.007, p:.008, p:.007 and p:.006, respectively). Dexmedetomidine has a protective effect against ischaemia-reperfusion injury in penile tissue.
Description
Keywords
dexmedetomidine, ischaemia reperfusion injury, priapism
Turkish CoHE Thesis Center URL
Fields of Science
Citation
WoS Q
Q3
Scopus Q
Source
Andrologia
Volume
53
Issue
3
Start Page
End Page
URI
https://www.scopus.com/record/display.uri?eid=2-s2.0-85100024639&doi=10.1111%2fand.13985&origin=inward&txGid=c9d4e0ce10fcab8d19291841b50d6c55&featureToggles=FEATURE_NEW_METRICS_SECTION:1
https://hdl.handle.net/20.500.12514/2683
https://doi.org/10.1111/and.13985
https://pubmed.ncbi.nlm.nih.gov/33474739/
https://hdl.handle.net/20.500.12514/2683
https://doi.org/10.1111/and.13985
https://pubmed.ncbi.nlm.nih.gov/33474739/